YOKNEAM, Israel, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (NASDAQ:LMNS), the world's largest energy-based medical device company for aesthetic, surgical, and ophthalmology applications, announced the launch of a new online informational resource, AesthetiPedia. AesthetiPedia provides information about the latest energy-based skincare treatments for individuals seeking to address common skin concerns such as pigmentation, hair removal and overall rejuvenation. The website includes key facts about each skin condition, overviews of available treatment options and an extensive before-and-after picture collection.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34869
"AesthetiPedia is a great resource for skincare professionals to share with their patients because the information on the site can serve as a jumping off point for discussions about treatment options," said Dr. Sabrina Fabi, MD, Dermatolgist and Cosmetic Surgeon at Cosmetic Laser Dermatology in San Diego, Calif. "It also provides patients with a simple way to find a skincare professional in their community who offers the latest laser- and energy-based procedures."
Conditions addressed on the site include age and sun spots, acne scars, fine lines and wrinkles, unwanted hair, stretch marks, scars, broken facial capillaries, birthmarks, leg veins, rosacea, and more. AesthetiPedia also provides information about treatment options, including procedures such as intense pulsed light (IPL), non-ablative skin resurfacing, and hair reduction.
The site's Find a Center feature allows patients to select their treatment of interest and find a qualified practice near their location where they can consult with a dermatologist or aeshtetician.
"As a worldwide leader in the aesthetic community, we are pleased to launch AesthetiPedia as part of our continued commitment to providing superior performance and service to our customers," said Tzipi Ozer-Armon, CEO of Lumenis. "This new user-friendly website provides beneficial skincare information while connecting patients with physicians who provide the latest treatment technology for the best possible results."
AesthetiPedia also features regular skincare tips from leading dermatologists on fresh beauty topics such as how to achieve a radiant complexion and the best way to protect your skin from sun damage.
To access AesthetiPedia and learn more about your personal skincare, please visit www.aesthetipedia.com.
Lumenis (NASDAQ:LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. For more information visit: www.lumenis.com
Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include but are not limited to the Company's plans, objectives and expectations for future operations, including its projected results of operations. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "plan," "project" or other similar words, but are not the only way these statements are identified. These forward-looking statements are based upon our management's current estimates and projections of future results or trends. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including those risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: For further information: Glenn Silver Lazar Partners Ltd. (646) 871-8485